Latest News

Featured

May 24, 2022

LIFNano-Rx's Board grows in strength with David Leppert M.D. - world-renowned MS neurologist and corporate Global Medical Officer - taking up position as Director

May 24, 2022

Oct 11, 2021

BREAKING NEWS FROM LIFNANO-Rx

Oct 11, 2021

Aug 5, 2021

Andrew Foxley, VP - R&D Franchise Head at AstraZeneca, joins the Board

Aug 5, 2021

May 25, 2021

A note from our CEO

May 25, 2021

May 13, 2021

LIFNano and InkJet Prinitng

May 13, 2021

Apr 8, 2021

LIFNano and Healing: a new Human Meta-analysis identifies Treg as key

Apr 8, 2021

Mar 2, 2021

Invitation To Speak EPSRC MITHRAS Consortium

Mar 2, 2021

International Standing

Mar 2, 2021

Jul 28, 2020

Two New Board Appointments support LIFNano's progress into Clinical Trials

Jul 28, 2020

We are delighted to announce Dr Andrew Carver's appointment as non-executive Director to LIFNano's Board, together with appointment of Professor Alan Boyd who joins our Board as Advisor.

Jul 28, 2020

Jun 19, 2019

Elected to the Board of European Technology Platform - NanoMedicine

Jun 19, 2019

Our Founder and CEO Dr Su Metcalfe is elected to the Board of the European Technology Platform - NanoMedicne (ETPN)

Jun 19, 2019

Mar 8, 2019

CEO and Founder named in 40 most brave, brilliant and intelligent women in Cambridgeshire

Mar 8, 2019

Our Founder and CEO Su Metcalfe is honoured to be included in Cambridgeshire's List of 40 most brave, brilliant and intelligent women as part of this year’s World Woman’s Day.

Mar 8, 2019

Feb 25, 2019

7th Molecular Mechanisms of Axon Degeneration Bi-Annual Meeting 2019

Feb 25, 2019

Dr Su Metcalfe is to discuss LIFNano's powerful repair properties that protect nerves at this internationally acclaimed academic meeting series on 11th - 14th March 2019 in Loch Lomond, UK.

Feb 25, 2019

Feb 22, 2019

Shaping the UK-Bulgarian Biotech Future

Feb 22, 2019

LIFNano is to be showcased as representing British Excellence and Innovation at The British Embassy in Sofia, Bulgaria 15th March 2019

Feb 22, 2019

Oct 30, 2018

LIFNano to join Lord Bilimoria at the House of Lords

Oct 30, 2018

Our Founder and CEO, Su Metcalfe, will join Lord Bilimoria, British Indian entrepreneur and a life peer, at the House of Lords for the All-Party Parliamentary Group (APPG) for Entrepreneurship launch of a report on Enterprise Education at Universities on Nov 14th 2018.

Oct 30, 2018

Oct 26, 2018

Multiple Sclerosis at the Limits 2018

Oct 26, 2018

LIFNano's Su Metcalfe is joining global opinion leaders in MS who will be presenting latest advances in MS management and treatment. The meeting is to be Chaired by Professor Gavin Giovannoni (London; member of LIFNano's Advisoory Board) and William Carroll (Perth Australia).

Oct 26, 2018

Oct 14, 2018

LIFNano is invited to join in celebrations of 130 Years of the Cambridge News

Oct 14, 2018

On October 17th, LIFNano's President Su Metcalfe is honored to be joining CAMBRIDGE'S MOST INFLUENTIAL BUSINESS'S by kind invitation of Cambridge News and Media. An excellent opportunity to engage on behalf of our wider community of supporters and MS'ers"

Oct 14, 2018

Sep 10, 2018

Brain Delivery Technologies for CNS Therapeutics

Sep 10, 2018

At the upcoming International Meeting in Munich, Su Metcalfe will be presenting the unique properties of LIFNano for treatment of MS, including successful delivery of LIFNano across the blood-brain barrier. 4th Annual Neuroscience R&D Technologies Conference 4th -5th October 2018 Munich Germany.

Sep 10, 2018

Aug 28, 2018

New Advisor joins LIFNano's Advisory Team

Aug 28, 2018

We are delighted to welcome Andrew Carver who brings experience in the development and cGMP manufacture of recombinant therapeutic biologics.

Aug 28, 2018

Jul 16, 2018

LIFNano at The House of Lords

Jul 16, 2018

Following kind invitation from The Rt Hon Liam Byrne MP and Baroness Kramer, our founder Dr Su Metcalfe will attend the launch of three Government briefing papers, including Women in Leadership, at the House of Lords.

Jul 16, 2018

May 14, 2018

The Pathway To Clinical Trials

May 14, 2018

Our vision for the first clinical trial in multiple sclerosis is on course for 2020, supported by a UK government funding award.

May 14, 2018

May 7, 2018

Benefits of engaging with the UK MS Register

May 7, 2018

If you are not already familiar with it, we would like to draw your attention to the UK MS Register.

May 7, 2018

Apr 18, 2018

Prizes, Recognition and Fund Raising

Apr 18, 2018

In November in Berlin, we were delighted to receive the GLOBAL AWARD FOR NANOMEDICINE 2017, a highly prestigious prize.

Apr 18, 2018

Mar 26, 2018

A Tribute To Terry B Strom

Mar 26, 2018

We are deeply saddened to hear of the death of Terry Strom, pioneering clinical transplant immunologist who worked with our Founder in the discovery of LIF's role in immune self-tolerance.

Mar 26, 2018

Mar 7, 2018

Welcome to Robert Clay

Mar 7, 2018

Robert brings to LIFNano expertise in delivering Regulatory approval required as we progress to Clinical Trials.

Mar 7, 2018

Feb 28, 2018

Latest LIFNano Publication

Feb 28, 2018

Dr Su Metcalfe's new academic paper has been published in the Journal "Multiple Sclerosis and Related Disorders" entitled "LIF and multiple sclerosis: One protein with two healing properties".

Feb 28, 2018

Nov 7, 2017

LIFNano™ wins global medicine award for its ground-breaking potential MS treatment

Nov 7, 2017

A leading scientist battling to halt the development of Multiple Sclerosis has revealed that clinical human trials will start by 2020, after her company was honoured with a major nano medicine award.

Nov 7, 2017

News Archive

November 2017
• In the news again!
We are honoured to have been awarded a major international nanomedicine award at the European Technology Platform on Nanomedicine Awards in Berlin. Read more here: Most Promising Nanomedicine Project.
• Welcome to Andrew Foxley!
We are very pleased to announce that Andrew has joined our Advisory Board, bringing significant expertise in drug development. Andrew is the Scientific & Project Management & Clinical Programme Director for AZD5363, Astra Zeneca, and the AZ Representative on the Experimental Medicine Expert Network of the ABPI. Read more in Andrew's LinkedIn profile.

October/November 2017

Presenting, networking, building relationships...
Su Metcalfe will be presenting at three international conferences in the coming weeks:
ECTRIMS, Paris, 25-28 October
BIO-Europe, Berlin, 6-8 November
Boston Biotech - Europe CEO Conference, London, 14 November

September 2017
• Mentioned in dispatches again!
LIFNanoRx is Highly Commended in the Biotech section of the Cambridge Independent Entrepreneurial Science and Technology Awards. Read more in the Cambridge Independent article.

June 2017
• Great article highlighting our partnership with Yale University
Read more in the New Haven Register.

May 2017
• Su Metcalfe interviewed by Matthew Gooding, Cambridge Business Magazine
A great summary of the LIFNanoRx story so far: Article from Cambridge Business Magazine, June 2017 Edition

MARCH 2017
• Su wins Business Weekly's Woman Entrepreneur of the Year Award 2017
Su was selected from a shortlist of nine competitors to win the Business Weekly Woman Entrepreneur of the Year Award for 2017. The award is sponsored by the Judge Business School in the University of Cambridge. See the Judge Business School website for more information.

• Conferences
Su will be speaking at two international conferences in March:
• Building Bridges in Medical Sciences. Cambridge UK, 10th March
• 8th International Congress: Nanotechnology in Biology and Medicine. Krems, Austria, 20-22 March

FEBRUARY 2017
• Nanomedicine - how to accelerate translation from research to market
LIFNanoRx will be contributing expert advice on the subject of 'How to pitch' to the NanoMedNorth Breakfast Seminar in Stockholm, on 6th February.

DECEMBER 2016
• New CEO
We're delighted to welcome Olivier Jarry, our new Chief Executive Officer. Olivier has significant global experience and expertise in biopharma, biotechnologies, investment and strategy in the healthcare and digital health fields. Click here for more information about Olivier and the rest of our Management Team.

• New Chairman
After providing a much valued role in supporting LIFNanoRx's early start-up development, Mark Goodridge has now stepped down as Director and Chairman of the Board. LIFNanoRx has now become a major commercial enterprise and, as this new chapter in the company's story opens, we are delighted to welcome Florian Kemmerich as our new Chairman, linking LIFNano to a global network of expertise in taking new therapeutics to patients.

NOVEMBER 2016
• LIFNanoRx is awarded £1 million to prepare for first-in-man clinical trials.
Through the Government's Innovation funding arm, "Innovate-UK", LIFNanoRx has been awarded one million pounds from the BioMedical Catalyst Competition. The awarded Project has been designed by LIFNanoRx to ensure efficient progress in bringing the value of LIF to patients with MS. Production of clinical-grade nanoparticles will parallel planning of an early trial in MS to start 2020/2021. The Project's team include clinical partner Gavin Giovannoni (London) who will lead the trials; the Government's specialist manufacturing Centre - CPI; and Pharmidex who complete the team, working to meet regulatory requirements prior to clinical use. The award - gained despite fierce competition - is evidence of the UK Government's recognition of NanoMedicine. Equally, the award is recognition of LIFNanoRx as a strong commercial enterprise with the ability to bring our innovative therapy to treat MS on global scale.

APRIL 2016
• Following the immensely valuable Pitch@Palace event last month, LIFNanoRx will be in Manchester on the 21st and 22nd of April for another great innovation forum: Business Rocks 2016. We're looking forward to rubbing shoulders with Steve Wozniak, co-founder of Apple, who will also be speaking at the event.

FEBRUARY 2016
• Su Metcalfe presenting to The Duke of York, other distinguished guests, and other Biotech entrepreneurs at the Pitch@Palace event in February 2016. Thanks to the Duke of York for the opportunity to participate, and to the Judge Business School in the University of Cambridge for their amazing support.

• LIFNano Therapeutics is in receipt of a I-UK Smart Award for Proof of Concept: £100,000. This is matched by the Merck Serono GMSI 2014 award to Su Metcalfe £150,000 at the Cambridge Biomedical Campus, Addenbrooke's Hospital, Cambridge.

• Both the Cambridge Judge Business School and Enterprise East are supporting LIF-Nano Therapeutics including through the University's Entrepreneurship Accelerate Program.